These cells constitute a small fraction of the tumor population and present “migration” tendencies (which helps to explain the infiltrative nature of GBM); CSCs are able to give rise to CD33- differentiated clones, demonstrating a higher potential growth rate thus contributing to the genesis of the “tumor-bulk” [31,32,33]. This evidence concerns the gene CD33 and glioblastoma.